Global Pain Therapeutics Market to 2029 - Featuring Abbott Laboratories, AstraZeneca and GlaxoSmithKline Among Others
28 mars 2022 07h33 HE
|
Research and Markets
Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "Pain Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...
Insights on the Cancer Pain Global Market to 2030 - Rising Healthcare Expenditure and Government Support Worldwide are Driving Growth
09 mars 2022 04h58 HE
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Pain Market, By Drug Type, By Disease Indication, Estimation & Forecast, 2017 - 2030" report has been added to...
Global Opioid Analgesics Market Review 2016-2020 and Forecast 2021-2031 | Increasing Prevalence of Chronic Disease & Surgical Procedures and Neuropathic & Chronic Pain
15 déc. 2021 05h03 HE
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Opioid Analgesics Market Forecast, Trend Analysis & Opportunity Assessment 2021-2031" report has been added to ResearchAndMarkets.com's offering....
Worldwide Opioid Drugs Industry to 2029 - by Drug Type, Application and Geography
14 oct. 2021 05h58 HE
|
Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Opioid Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021...
First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
07 sept. 2021 08h30 HE
|
University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use...
Worldwide Industry for Pain Management Drugs to 2027 - Advancements in Drug Development Presents Opportunities
08 oct. 2020 05h09 HE
|
Research and Markets
Dublin, Oct. 08, 2020 (GLOBE NEWSWIRE) -- The "Pain Management Drugs Market by Drug Class and Indication: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to...
Global Opioid Drugs Markets 2019-2020 & Forecast to 2028: Increased Number of Lawsuits Against the Manufacturers of Opioid Drugs Restraining Growth
29 sept. 2020 06h24 HE
|
Research and Markets
Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Opioid Drugs Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global opioids drug market to proliferate with...
Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release
20 sept. 2017 08h37 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that it has filed an Abbreviated New Drug Application (ANDA) with...
Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference
30 août 2017 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for ELI-200 at PAINWeek 2017 National...
Elite Reports On SequestOx™ FDA End-of-Review Meeting
23 janv. 2017 08h18 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported the Company received official minutes from its December 21, 2016...